Screener
CorMedix CRMD Total Revenue
Discontinued — last reported Q2 '26
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: CorMedix’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 8:07 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001410098-26-000056
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product sales, net | $94,341 | $39,736 | $216,257 | $78,818 |
| Contract revenue | 4,966 | - | 8,048 | - |
| Grant income | 2,624 | - | 5,053 | - |
| Total Revenue and Grant Income | $101,931 | $39,736 | $229,358 | $78,818 |
| Cost of sales (exclusive of amortization of intangibles) | 14,505 | 1,810 | 26,510 | 3,355 |
| Amortization of intangibles | 10,300 | 52 | 20,600 | 104 |
| Gross profit | $77,126 | $37,874 | $182,248 | $75,359 |
| Operating Expenses: |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's total revenue?
- CorMedix (CRMD) reported total revenue of $101.93M in Q2 2026.
- How has CorMedix's total revenue changed year-over-year?
- CorMedix's total revenue increased by 156.5% year-over-year, from $39.74M to $101.93M.
- What is the long-term trend for CorMedix's total revenue?
- Over 3 years (2021 to 2025), CorMedix's total revenue has grown at a 1077.5% compound annual growth rate (CAGR), from $190.94K to $311.71M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about CorMedix's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude